Oncology

MONARCH 2 Trial - Clinical Impact on Clinical Practice

By :
Dr. Meteb Al Foheidi / Dr. Mark Verrill
Oncology

Delay of Chemotherapy in Patients Receiving Abemaciclib + Fulvestrant

By :
Dr. Meteb Al Foheidi / Dr. Mark Verrill
Oncology

MONARCH 2 Trial - Patient Characteristics and OS Results

By :
Dr. Meteb Al Foheidi / Dr. Mark Verrill
Oncology

Safety and Tolerability of Abemaciclib & Patient Counseling

By :
Dr. Meteb Al Foheidi / Dr. Mark Verrill
Oncology

MONARCH 2 Trial - Maturity of OS Results

By :
Dr. Meteb Al Foheidi / Dr. Mark Verrill
Oncology

Patient selection for Abemaciclib

By :
Prof. Alistair Ring
Oncology

How to Manage Side Effects of Abemaciclib

By :
Prof. Stephen Johnston
Oncology